Luisa Foltran
Aviano, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Predictive biomarkers for cetuximab-based rechallenge therapy in metastatic colorectal cancer: a pooled analysis of the CAVE and CAVE-2 GOIM studies.
Journal: ESMO gastrointestinal oncology
Published: August 28, 2026
Prolonged response to combined BRAF and MEK inhibition in BRAF mutant colorectal cancer, a case report.
Journal: Frontiers in oncology
Published: March 13, 2026
DPYD and UGT1A1 Genotype-Based Dosing for Fluoropyrimidines and Irinotecan Chemotherapy: Variant-Specific Impact on Treatment Intensity and Toxicity.
Journal: International journal of cancer
Published: February 24, 2026
Triplet chemotherapy combined with anti Epidermal Growth Factor Receptor treatment in RAS wild-type colorectal cancer: a network metanalysis.
Journal: The oncologist
Published: October 12, 2025
Chemoradiotherapy for Oesophageal Adenocarcinoma: The Debate is Not Over.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: June 24, 2025
Multidisciplinary Clinic Approach Improves Immunotherapy Treatment Outcomes in Unresectable Hepatocellular Carcinoma: A Multicentre Retrospective Study.
Journal: Liver cancer
Published: June 21, 2025
Anti-HER2 Therapies in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
Journal: The oncologist
Published: June 06, 2025
Fournier's Gangrene During Lenvatinib Treatment for Hepatocarcinoma.
Journal: Cureus
Published: April 24, 2025
Precision oncology in biliary tract cancer: the emerging role of liquid biopsy.
Journal: ESMO open
Published: December 29, 2024
Clinical Benefits and Utility of Pretherapeutic DPYD and UGT1A1 Testing in Gastrointestinal Cancer: A Secondary Analysis of the PREPARE Randomized Clinical Trial.
Journal: JAMA network open
Published: December 06, 2024
Adjuvant TRastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual disease in liquid biopsy after pre-operative chemotherapy and radical surgery: the multicentre, phase II randomized TRINITY trial.
Journal: BMC cancer
Published: September 23, 2024
Liquid biopsy in colorectal cancer: Onward and upward.
Journal: Critical reviews in oncology/hematology
Published: October 05, 2023
Last Updated: 09/26/2026